NCT00025636 2013-09-17Combination Chemotherapy and Peripheral Stem Cell Transplant in Treating Patients With Relapsed Hodgkin's LymphomaNational Cancer Institute (NCI)Phase 3 Unknown220 enrolled
NCT00908180 2013-08-02Carmustine, Etoposide, Cytarabine, Melphalan, and Alemtuzumab Followed by Donor Stem Cell Transplant in Treating Patients With Relapsed or Refractory Hodgkin LymphomaNational Cancer Institute (NCI)Phase 2 Unknown47 enrolled